-
Location
Virtual via Zoom
Event Type
Sixth Annual Hematology Symposium
Sixth Annual Hematology Symposium
Outlook
Google
iCalPurpose
The 6th Annual Hematology Symposium will feature regional and national experts bringing you state-of-the-art updates on CLL, Hemorrhagic Shock and Resuscitation, Hemostasis Testing and ROTEM, RN/NP Considerations in Hematology/Oncology Transplant, Updates in Multiple Myeloma, Autologous and Allogeneic HSCT, Hyperhaemolysis and other TM Considerations in SCD, and updates in Sickle Cell Disease.
Target Audience
This activity was developed for primary care physicians, nurses, nurse practitioners, physician assistants, and other professionals with an interest in hematology.
Activity Objectives
- As a result of attending this course, I am better able to recognize emerging options in the management of sickle cell disease.
- Use of antifibrinolytics is indicated when ROTEM tracings demonstrate hyperfibrinolysis in a bleeding patient.
- As a result of attending this course, I am better able to recognize the role of Hematopoietic Stem Cell Transplant and Cellular Therapies in selected states.
Attendance & Evaluation for CME Credit
In order to account for attendance and receive CME credit for participating through Zoom, please click on this link and complete the evaluation.
Evaluation links will close on Sunday, April 11, 2021 at 11:00pm
Full disclosure information from all those in control of content will be provided in advance of the activity.
Accreditation Statement
The University of California, Irvine School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The University of California, Irvine School of Medicine designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures
All of the course directors, planners, speakers, moderators, and peer reviewers have nothing to disclose, except those shown below.
The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views of the University of California, Irvine School of Medicine.
|
Name |
Role |
Company |
Relationship |
|
Pamela Becker, MD, PhD |
Presenter |
Accordant Abbvie BMS Cardiff Oncology CVS Caremark Glycomimetics JW Pharmaceutical Novartis Pfizer SecureaBio |
Advisor or Review Panel Member Grant/Research Support Grant/Research Support Grant/Research Support Advisor or Review Pandel Member Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support |
|
Elizabeth Brem, MD |
Presenter |
Bayer BeiGene BeiGene Karyopharm Morphosys Pharmacyclics/Jannssen |
Advisor or Review Panel Member Speaker's Bureau Advisor or Review Panel Member Advisor or Review Panel Member Advisor or Review Panel Member Speaker's Bureau |
|
Stefan Ciurea, MD |
Presenter |
Kiadis Miltenyi Biotech |
Consultant, Honorarium Recipient, Stock Shareholder Grant/Research Support |
|
Susan O'Brien, MD |
Presenter |
Abbvie Acerta Alexion Amgen Aptose Biosciences Inc. Astellas Autolus BMS Celgene Eisai Gilead GlaxoSmithKline Janssen Oncology Johnson and Johnson June Therapeutics Kite Merck Pfizer Pharmacyclics Regeneron Sunesis TG Therapeutics Vaniam Group LLC Verastem Vida Ventures |
Consultant Research Support Consultant Consultant Consultant Consultant Consultant Consultant Consultant Consultant Consultant, Research Support Consultant Consultant Consultant Consultant Research Support Consultant Consultant, Research Support Consultant, Research Support Research Support Consultant, Research Support Consultant, Research Support Consultant Consultant Consultant |
|
Zahra Pakbaz, MD |
Presenter |
Amgen Dova Novartis Sanofi Terumo BCT |
Advisor or Review Panel Member Advisor or Review Panel Member Advisor or Review Panel Member, Speaker's Bureau Advisor or Review Panel Member, Honorarium Recipient Advisor or Review Panel Member, Independent Contractor, Speaker's Bureau |
All conflicts have been mitigated in advance.
7:50 - 8:00 a.m.
Welcome and Opening RemarksMinh-Ha Tran, DO
UCI School of Medicine8:00 - 8:50 a.m.
RN/NP Considerations in Hem/Onc/TransplantMaureen Carr, BSN, MSN
UCI School of Medicine8:50 - 9:40 a.m.
Hemorrhagic Shock and Resuscitation
Jeffry Nahmias, MD, MHPE, FACS
UCI School of Medicine9:40 – 10:30 a.m.
Hemostasis Testing and ROTEM
Jennifer S. Woo, MD
UCI School of Medicine10:30 – 11:00 a.m. Break
11:00 – 11:50 a.m.
Updates in CLL
Susan M. O'Brien, MD
UCI School of Medicine, UCI Health
11:50 – 12:20 p.m. Lunch Break
12:20 – 1:10 p.m.
Updates in AML
Pamela Becker, MD, PhD
UCI School of Medicine1:10 – 2:00 p.m.
New and Upcoming Therapies in Lympomas
Elizabeth A. Brem, MD
UCI School of Medicine2:00 - 2:50 p.m.
Updates on Hematopoietic Stem Cell Transplantation for AML
Stefan O. Ciurea, MD
UCI School of Medicine, UCI Health2:50 - 3:20 p.m. Break
3:20 - 4:10 p.m.
Hyperhemolysis and Other TM Considerations in SCD
Ross Fasano, MD
UCI School of Medicine4:10 - 5:00 p.m.
Updates in Sickle Cell Disease
Zahra Pakbaz, MD
UCI School of Medicine5:00 p.m. Closing Remarks, invitation to next year
Minh-Ha Tran, DO
UCI School of Medicine
Featured
Minh-Ha Tran, DO
- Professor of Pathology & Laboratory Medicine, UCI School of Medicine
Course Director
Elizabeth A. Brem, MD
- Assistant Professor of Hematology/Oncology, Department of Medicine, UCI School of Medicine
Course Faculty
Jeffry Nahmias, MD, MHPE, FACS
- Associate Clinical Professor of Surgery, Director of the Surgical Intensive Care Unit, Director of the Surgical Telemetry & Surgical Step Down Units, Co-Director of Department of Surgery Research, UCI School of Medicine
Jennifer S. Woo, MD
- Clinical Professor of Pathology & Laboratory Medicine, UCI School of Medicine
Maureen Carr, BSN, MSN
- Nurse Practitioner of Hematology/Oncology, Department of Medicine, UCI School of Medicine
Pamela Becker, MD, PhD
- Professor of Hematology/Oncology, Department of Medicine, UCI School of Medicine
Ross Fasano, MD
- Professor of Pathology & Laboratory Medicine, Director of Transfusion Medicine Fellowship Program, Emory University School of Medicine
Stefan O. Ciurea, MD
- Professor of Hematology/Oncology, Department of Medicine, UCI School of Medicine; Director of Hematopoietic Stem Cell Transplant and Cellular Therapy Program, UCI Health
Susan M. O'Brien, MD
- Professor of Hematology/Oncology, Department of Medicine, UCI School of Medicine; Associate Director for Clinical Science, Chao Family Comprehensive Cancer Center, UCI Health
Zahra Pakbaz, MD
- Associate Professor of Hematology/Oncology, Department of Medicine, UCI School of Medicine